Drugs / Jiuweihuaban Pill
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT06058546 | Nov 2023 → Oct 2025 overdue | psoriasis | Tasly Pharmaceutical Group Co., Ltd | Recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Jiuweihuaban Pill | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06058546 ↗ |
| Route | Oral | “Low dose Jiuweihuaban pill 1 bag(3 g placebo per bag and 9 g Jiuweihuaban pill ),p.o.,tid,for 12weeks.” NCT06058546 ↗ |